Transcatheter closure of single secundum atrial defects has become the standard of
treatment. The purpose of our study was to analyze the results of using a single Amplatzer …

Objective To prospectively study the techniques and outcomes of transcatheter closure of
complex Atrial septal defects (ASD). Study design and settings Prospective single center …

Objectives: The goal of this study was to report the early and late complications experienced
in atrial septal defect (ASD) transcatheter closure. Background: Atrial septal defect …

Aim: To evaluate the safety and efficacy of transcatheter closure of secundum atrial septal
defects (ASD) with the Amplatzer septal occluder. Methods: 236 consecutive patients with a …

The objective of this study was to describe a new technique for transcatheter device closure
of large atrial septal defects (ASDs) using the Amplatzer septal occluder and our experience …

Percutaneous closure of atrial septal defects (ASD) is increasingly performed in pediatric
and adult patients. This study reports a single-center experience with the use of the …

Atrial septal defect (ASD) is one of the most common congenital heart defects, accounting for
7%-10% of all congenital heart disease (CHD) in children and 30%-33% of defects …

Transcatheter closure of secundum type atrial septal defect has become an accepted
alternative to surgical closure. Closure of small to moderate-sized atrial septal defects is …

BACKGROUND: The HELEX septal occluder is a new transcatheter atrial septal defect
occlusion device. This study analyzes the data collected from the first US clinical trials with …

Objective To report initial findings from a selected group of patients with morphological
variations of the atrial septal defect who underwent transcatheter closure with a second …